Modulation of autonomic balance by tumors and viruses

Medical Hypotheses

Volumn 63, Issue 2, 2004, Pages 344-351

  Yun, A Joon ^a   Lee, Patrick Y ^a   Bazar, Kimberly A ^b  

^a STANFORD UNIVERSITY   (United States)

^b San Mateo Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE;

AUTONOMIC NERVOUS SYSTEM; AUTONOMIC NERVOUS SYSTEM FUNCTION; BEHAVIOR; BODY DISTRIBUTION; CACHEXIA; CYTOKINE PRODUCTION; ENDOCRINE FUNCTION; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HERPES SIMPLEX VIRUS 1; HOST; HOST PATHOGEN INTERACTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERTROPHIC OSTEOARTHROPATHY; IMMUNE RESPONSE; IMMUNOREGULATION; INSOMNIA; NEUROMODULATION; NONHUMAN; PARANEOPLASTIC SYNDROME; PHYSICAL STRESS; PRIORITY JOURNAL; QT PROLONGATION; REVIEW; SIGNAL TRANSDUCTION; STRESS; SURVIVAL; SYMPATHETIC FUNCTION; TUMOR; TUMOR GROWTH; VIROGENESIS; VIRUS INFECTION;

DARWINIA;

EID: 3242754352     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2004.02.029     Document Type: Editorial

References (112)

1. Calvet X., Martinez J.M., Martinez M. Repeated neostigmine dosage as palliative treatment for chronic colonic pseudo-obstruction in a patient with autonomic paraneoplastic neuropathy. Am. J. Gastroenterol. 98(3):2003;708-709
2. Nathanson L., Hall T.C. Introduction: paraneoplastic syndromes. Semin. Oncol. 24(3):1997;265-268
3. Mordes J.P., Rossini A.A. Tumor-induced anorexia in the Wistar rat. Science. 213(4507):1981;565-567
4. Sato K., Onuma E., Yocum R.C., Ogata E. Treatment of malignancy- associated hypercalcemia and cachexia with humanized anti-parathyroid hormone-related protein antibody. Semin. Oncol. 30(5 Suppl 16):2003;167-173
5. Torley D., Bellus G.A., Munro C.S. Genes, growth factors and acanthosis nigricans. Br. J. Dermatol. 147(6):2002;1096-1101
6. Cruz P.D. Jr., Hud J.A. Jr. Excess insulin binding to insulin-like growth factor receptors: proposed mechanism for acanthosis nigricans. J. Invest. Dermatol. 98(6 Suppl):1992;82S-85S
7. Vassilopoulou-Sellin R., Cangir A., Samaan N.A. Acanthosis nigricans and severe insulin resistance in an adolescent girl with thyroid cancer: clinical response to antineoplastic therapy. Am. J. Clin. Oncol. 15(3):1992;273-276
8. Koyama S., Ikeda K., Sato M., et al. Transforming growth factor-alpha (TGF alpha)-producing gastric carcinoma with acanthosis nigricans: an endocrine effect of TGF alpha in the pathogenesis of cutaneous paraneoplastic syndrome and epithelial hyperplasia of the esophagus. J. Gastroenterol. 32(1):1997;71-77
9. Haase I., Hunzelmann N. Activation of epidermal growth factor receptor/ERK signaling correlates with suppressed differentiation in malignant acanthosis nigricans. J. Invest. Dermatol. 118(5):2002;891-893
10. Korc M. Role of growth factors in pancreatic cancer. Surg. Oncol. Clin. N. Am. 7(1):1998;25-41
11. Foster B.A., Kaplan P.J., Greenberg N.M. Peptide growth factors and prostate cancer: new models, new opportunities. Cancer Metastasis Rev. 17(4):1998-1999;317-324
12. Mizejewski G.J. Role of integrins in cancer: survey of expression patterns. Proc. Soc. Exp. Biol. Med. 222(2):1999;124-138
13. Bikle D.D., Xie Z., Ng D., et al. Squamous cell carcinomas fail to respond to the prodifferentiating actions of 1,25 (OH)2D: why? Recent Res. Can. Res. 164:2003;111-122
14. Peng J.B., Zhuang L., Berger U.V., et al. CaT1 expression correlates with tumor grade in prostate cancer. Biochem. Biophys. Res. Commun. 282(3):2001;729-734
15. Levitzki A. Signal-transduction therapy. A novel approach to disease management. Eur. J. Biochem. 226(1):1994;1-13
16. van der Pompe G., Antoni M.H., Heijnen C.J. Elevated basal cortisol levels and attenuated ACTH and cortisol responses to a behavioral challenge in women with metastatic breast cancer. Psychoneuroendocrinology. 21(4):1996;361-374
17. Germer A., Enzmann V.V., Drossler K. Arginine-vasopressin influences the mitogen-induced development of T and B effector cells. Endocr. Regul. 30(1):1996;13-17
18. Shibasaki T., Hotta M., Sugihara H., Wakabayashi I. Brain vasopressin is involved in stress-induced suppression of immune function in the rat. Brain Res. 808(1):1998;84-92
19. Suzuki S., Okudaira S. Maternal peripheral T helper 1-type and T helper 2-type immunity in women during the first trimester of twin pregnancy. Arch. Gyn. Obstet. 2003;. Epub October 10
20. Refojo D., Liberman A.C., Giacomini D., et al. Integrating systemic information at the molecular level: cross-talk between steroid receptors and cytokine signaling on different target cells. Ann. N. Y. Acad. Sci. 992:2003;196-204
21. Aoki K., Nakajima A., Mukasa K., et al. Prevention of diabetes, hepatic injury, colon cancer with dehydroepiandrosterone. J. Ster. Bioch. Mol. Biol. 85(2-5):2003;469-472
22. Inserra P., Zhang Z., Ardestani S.K., et al. Modulation of cytokine production by dehydroepiandrosterone (DHEA) plus melatonin (MLT) supplementation of old mice. Proc. Soc. Exp. Biol. Med. 218(1):1998;76-82
23. Zhang Z., Inserra P.F., Liang B., et al. Melatonin, immune modulation and aging. Autoimmunity. 26(1):1997;43-53
24. Garcia-Maurino S., Pozo D., Carrillo-Vico A., et al. Melatonin activates Th1 lymphocytes by increasing IL-12 production. Life Sci. 65(20):1999;2143-2150
25. Sudo N., Yu X.N., Kubo C. Dehydroepiandrosterone attenuates the spontaneous elevation of serum IgE level in NC/Nga mice. Immunol. Lett. 79(3):2001;177-179
26. Kuhlwein E., Irwin M. Melatonin modulation of lymphocyte proliferation and Th1/Th2 cytokine expression. J. Neuroimmunol. 117(1-2):2001;51-57
27. Fett D.L., Gibson L.E., Su W.P. Sweet's syndrome: systemic signs and symptoms and associated disorders. Mayo Clin. Proc. 70(3):1995;234-240
28. Benyahia B., Amoura Z., Rousseau A., et al. Paraneoplastic antineuronal antibodies in patients with systemic autoimmune diseases. J. Neurooncol. 62(3):2003;349-351
29. Posner J.B. Immunology of paraneoplastic syndromes: overview. Ann. N. Y. Acad. Sci. 998:2003;178-186
30. Gill S., Murray N., Dalmau J., Thiessen B. Paraneoplastic sensory neuronopathy and spontaneous regression of small cell lung cancer. Can. J. Neurol. Sci. 30(3):2003;269-271
31. Adamus G. Autoantibody-induced apoptosis as a possible mechanism of autoimmune retinopathy. Autoimmun. Rev. 2(2):2003;63-68
32. Singh R.R. IL-4 and many roads to lupus like autoimmunity. Clin. Immunol. 108(2):2003;73-79
33. Link J. Interferon-gamma, interleukin-4 and transforming growth factor-beta mRNA expression in multiple sclerosis and myasthenia gravis. Acta Neurol. Scand. Suppl. 158:1994;1-58
34. Kero J., Gissler M., Hemminki E., Isolauri E. Could TH1 and TH2 diseases coexist? Evaluation of asthma incidence in children with coeliac disease, type 1 diabetes, or rheumatoid arthritis: a register study. J. Allergy Clin. Immunol. 108(5):2001;781-783
35. Bach J.F. Autoimmune diseases as the loss of active self-control. Ann. N. Y. Acad. Sci. 998:2003;161-177
36. Meijer W.C., van Veldhuisen D.J., Kema I.P., et al. Cardiovascular abnormalities in patients with a carcinoid syndrome. Neth. J. Med. 60(1):2002;10-16
37. Thakker R.V. Multiple endocrine neoplasia. Horm. Res. 56(Suppl 1):2001;67-72
38. Ploegh H.L. Viral strategies of immune evasion. Science. 280(5361):1998;248-253
39. Gemma C., Smith E.M., Hughes T.K. Jr., Opp M.R. Human immunodeficiency virus glycoprotein 160 induces cytokine mRNA expression in the rat central nervous system. Cell Mol. Neurobiol. 20(4):2000;419-431
40. Rudikoff D. The relationship between HIV infection and atopic dermatitis. Curr. Allergy Asthma Rep. 2(4):2002;275-281
41. Kocheril A.G., Bokhari S.A., Batsford W.P., Sinusas A.J. Long QTc and torsades de pointes in human immunodeficiency virus disease. Pacing Clin. Electrophysiol. 20(11):1997;2810-2816
42. Varriale P., Saravi G., Hernandez E., Carbon F. Acute myocardial infarction in patients infected with human immunodeficiency virus. Am. Heart J. 147(1):2004;55-59
43. Baronzio G., Zambelli A., Comi D., et al. Proinflammatory and regulatory cytokine levels in AIDS cachexia. In Vivo. 13(6):1999;499-502
44. Eylar E.H., Lefranc C.E., Yamamura Y., et al. HIV infection and aging: enhanced Interferon- and Tumor Necrosis Factor-alpha production by the CD8+CD28-T subset. B.M.C. Immunol. 2(1):2001;10
45. Raymon L.P., Kimes A.S., Tabakoff B., London E.D. AIDS and sleep disorders: effect of gp120 on cerebral glucose metabolism. C. R. Seances Soc. Biol. Fil. 183(5):1989;407-418
46. Buijs R.M., la Fleur S.E., Wortel J., et al. The suprachiasmatic nucleus balances sympathetic and parasympathetic output to peripheral organs through separate preautonomic neurons. J. Comp. Neurol. 464(1):2003;36-48
47. Hofman M.A. Lifespan changes in the human hypothalamus. Exp. Gerontol. 32(4-5):1997;559-575
48. Bartness T.J., Song C.K., Demas G.E. SCN efferents to peripheral tissues: implications for biological rhythms. J. Biol. Rhythms. 16(3):2001;196-204
49. Peterlin B.M., Trono D. Hide, shield and strike back: how HIV-infected cells avoid immune eradication. Nat. Rev. Immunol. 3(2):2003;97-107
50. Damasio A.R., Van Hoesen G.W. The limbic system and the localisation of herpes simplex encephalitis. J. Neurol. Neurosurg. Psychiatry. 48(4):1985;297-301
51. Porges S.W. The Polyvagal Theory: phylogenetic contributions to social behavior. Physiol. Behav. 79(3):2003;503-513
52. Henke P.G., Ray A. Stress ulcer modulation by limbic system structures. Acta Physiol. Hung. 80(1-4):1992;117-125
53. Haas H.S., Schauenstein K. Neuroimmunomodulation via limbic structures - the neuroanatomy of psychoimmunology. Prog. Neurobiol. 51(2):1997;195-222
54. Charney D.S. Neuroanatomical circuits modulating fear and anxiety behaviors. Acta Psychiatr. Scand. Suppl. (417):2003;38-50
55. Peterlin B.M., Trono D. Hide, shield and strike back: how HIV-infected cells avoid immune eradication. Nat. Rev. Immunol. 3(2):2003;97-107
56. Tanyalcin T., Taskiran D., Topalak O., et al. The effects of chronic hepatitis C and B virus infections on liver reduced and oxidized glutathione concentrations. Hepatol. Res. 18(2):2000;104-109
57. Giordani L., Quaranta M.G., Malorni W., et al. N-acetylcysteine inhibits the induction of an antigen-specific antibody response down-regulating CD40 and CD27 co-stimulatory molecules. Clin. Exp. Immunol. 129(2):2002;254-264
58. Bengtsson A., Lundberg M., Avila-Carino J., et al. Thiols decrease cytokine levels and down-regulate the expression of CD30 on human allergen-specific T helper (Th) 0 and Th2 cells. Clin. Exp. Immunol. 123(3):2001;350-360
59. Kidd P. Th1/Th2 balance: the hypothesis, its limitations, implications for health and disease. Altern. Med. Rev. 8(3):2003;223-246
60. Barbaro G., Di Lorenzo G., Soldini M., et al. Vagal system impairment in human immunodeficiency virus-positive patients with chronic hepatitis C: does hepatic glutathione deficiency have a pathogenetic role? Scand. J. Gastroenterol. 32(12):1997;1261-1266
61. Verne G.N., Soldevia-Pico C., Robinson M.E., et al. Autonomic dysfunction and gastroparesis in cirrhosis. J. Clin. Gastroenterol. 38(1):2004;72-76
62. Wiegand M., Moller A.A., Schreiber W., et al. Alterations of nocturnal sleep in patients with HIV infection. Acta Neurol. Scand. 83(2):1991;141-142
63. Hall M., Vasko R., Buysse D., et al. Acute stress affects heart rate variability during sleep. Psychosom. Med. 66(1):2004;56-62
64. Carrington J., Walsh M., Stambas T., et al. The influence of sleep onset on the diurnal variation in cardiac activity and cardiac control. Sleep Res. 12(3):2003;213-221
65. Nunnari G., Nigro L., Palermo F., et al. Reduction of serum melatonin levels in HIV-1-infected individuals' parallel disease progression: correlation with serum interleukin-12 levels. Infection. 31(6):2003;379-382
66. Maestroni G.J. Therapeutic potential of melatonin in immunodeficiency states, viral diseases, and cancer. Adv. Exp. Med. Biol. 467:1999;217-226
67. Marshall L., Born J. Brain-immune interactions in sleep. Int. Rev. Neurobiol. 52:2002;93-131
68. Sakami S., Ishikawa T., Kawakami N., et al. Coemergence of insomnia and a shift in the Th1/Th2 balance toward Th2 dominance. Neuroimmunomodulation. 10(6):2002-2003;337-343
69. Maestroni G.J. The immunotherapeutic potential of melatonin. Expert Opin. Investig. Drugs. 10(3):2001;467-476
70. Mure M., Domino K.B., Lindahl S.G., et al. Regional ventilation-perfusion distribution is more uniform in the prone position. J. Appl. Physiol. 88(3):2000;1076-1083
71. Kreck T.C., Krueger M.A., Altemeier W.A., et al. Determination of regional ventilation and perfusion in the lung using xenon and computed tomography. J. Appl. Physiol. 91(4):2001;1741-1749
72. Musch G., Layfield J.D., Harris R.S., et al. Topographical distribution of pulmonary perfusion and ventilation, assessed by PET in supine and prone humans. J. Appl. Physiol. 93(5):2002;1841-1851
73. Glenny R.W., Bernard S., Robertson H.T., Hlastala M.P. Gravity is an important but secondary determinant of regional pulmonary blood flow in upright primates. J. Appl. Physiol. 86(2):1999;623-632
74. Hlastala M.P., Lamm W.J., Karp A., et al. Spatial distribution of hypoxic pulmonary vasoconstriction in the supine pig. J. Appl. Physiol. 2003;. Epub December 29
75. Kuriyama T., Latham L.P., Horwitz L.D., et al. Role of collateral ventilation in ventilation-perfusion balance. J. Appl. Physiol. 56:1984;1500-1506
76. Robertson H.T., Glenny R.W., Stanford D., et al. High-resolution maps of regional ventilation utilizing inhaled fluorescent microspheres. J. Appl. Physiol. 82(3):1997;943-953
77. Brimioulle S., Vachiery J.L., Brichant J.F., et al. Sympathetic modulation of hypoxic pulmonary vasoconstriction in intact dogs. Cardiovasc. Res. 34(2):1997;384-392
78. Fraser R.G., Pare P.D., Pare J.A., et al. Diagnosis of diseases of the chest. 3rd ed.:1991;W.B. Saunders, Philadelphia, PN
79. Mollers M., Aries S.P., Dromann D., et al. Intracellular cytokine repertoire in different T cell subsets from patients with sarcoidosis. Thorax. 56(6):2001;487-493
80. Jones R.E., Chatham W.W. Update on sarcoidosis. Curr. Opin. Rheumatol. 11(1):1999;83-87
81. Lim M.K., Im J.G., Ahn J.M., et al. Idiopathic pulmonary fibrosis vs. pulmonary involvement of collagen vascular disease: HRCT findings. J. Korean Med. Sci. 12(6):1997;492-498
82. Copley S.J., Wells A.U., Sivakumaran P., et al. Asbestosis and idiopathic pulmonary fibrosis: comparison of thin-section CT features. Radiology. 229(3):2003;731-736. Epub October 23
83. Padley S.P., Padhani A.R., Nicholson A., Hansell D.M. Pulmonary sarcoidosis mimicking cryptogenic fibrosing alveolitis on CT. Clin. Radiol. 51(11):1996;807-810
84. Westermann W., Schobl R., Rieber E.P., Frank K.H. Th2 cells as effectors in postirradiation pulmonary damage preceding fibrosis in the rat. Int. J. Radiat. Biol. 75(5):1999;629-638
85. Costabel U., Guzman J. Bronchoalveolar lavage in interstitial lung disease. Curr. Opin. Pulm. Med. 7(5):2001;255-261
86. Sharma R., Guleria R., Pande J.N. Idiopathic pulmonary fibrosis: newer concepts and management strategies. Indian J. Chest Dis. Allied Sci. 45(1):2003;31-49
87. Chan J.O., Moglia B.A., Reeves I.V., et al. Cardiorespiratory and stress hormone responses during first dose surfactant administration in neonates with RDS. Pediatr. Pulmonol. 17(4):1994;246-249
88. Bajaj B.K., Agarwal M.P., Ram B.K. Autonomic neuropathy in patients with hepatic cirrhosis. Postgrad. Med. J. 79(933):2003;408-411
89. Hosono M., Machida K., Honda N., Takahashi T., et al. Quantitative lung perfusion scintigraphy and detection of intrapulmonary shunt in liver cirrhosis. Ann. Nucl. Med. 16(8):2002;577-581
90. Reutershan J., Schmitt A., Dietz K., Fretschner R. Non-invasive measurement of pulmonary blood flow during prone positioning in patients with early acute respiratory distress syndrome. Clin. Sci. (Lond.). 106(1):2004;3-10
91. Pfeiffer B., Hachenberg T., Wendt M., Marshall B. Mechanical ventilation with permissive hypercapnia increases intrapulmonary shunt in septic and nonseptic patients with acute respiratory distress syndrome. Crit. Care Med. 30(2):2002;285-289
92. Ntoumenopoulos G., Greenwood K. Effects of cardiothoracic physiotherapy on intrapulmonary shunt in abdominal surgical patients. Aust. J. Physiother. 42(4):1996;297-303
93. Dodd-o J.M., Welsh L.E., Salazar J.D., et al. Effect of bronchial artery blood flow on cardiopulmonary bypass-induced lung injury. Am. J. Physiol. Heart Circ. Physiol. 286(2):2004;H693-H700
94. Hayano J., Yasuma F., Okada A., et al. Respiratory sinus arrhythmia. A phenomenon improving pulmonary gas exchange and circulatory efficiency. Circulation. 94(4):1996;842-847
95. Weyand C.M., Goronzy J.J. The pathogenic role of T lymphocytes in vasculitis. Sarcoidosis Vasc. Diffuse Lung Dis. 13(3):1996;217-220
96. Weyand C.M., Goronzy J.J. Molecular approaches toward pathologic mechanisms in giant cell arteritis and Takayasu's arteritis. Curr. Opin. Rheumatol. 7(1):1995;30-36
97. Gross W.L. Churg-Strauss syndrome: update on recent developments. Curr. Opin. Rheumatol. 14(1):2002;11-14
98. Sanders J.S., Stegeman C.A., Kallenberg C.G. The Th1 and Th2 paradigm in ANCA-associated vasculitis. Kidney Blood Press. Res. 26(4):2003;215-220
99. Alcock J. Animal Behavior: an evolutionary approach. 7th ed.:2001;Sinauer Associates, Sunderland, MA
100. Lloyd J.E. Aggressive mimicry in Photuris fireflies: signal repertoires by femmes fetales. Science. 197:1975;452-453
101. Munn C.A. Birds that "cry wolf" Nature. 319:1986;143-145
102. Haftorn S. Contexts and possible functions of the alarm call in the willow tit, Parus montanus: The principle of "better safe than sorry" Behavior. 137:1999;437-449
103. Cristy J.H. Mimicry, mate choice, the sensory trap hypothesis. American Naturalist. 146:1995;171-181
104. Yun AJ, Lee PY, Bazar KA. Many diseases reflect dysfunctions of autonomic balance due to evolutionary displacement. Med Hypoth 2004; in press, doi:10.1016/j.mehy.2004.02.006
105. Hirvonen H., Salmi T.T., Heinonen E., et al. Vincristine treatment of acute lymphoblastic leukemia induces transient autonomic cardioneuropathy. Cancer. 64(4):1989;801-805
106. Dormann A.J., Grunewald T., Wigginghaus B., Huchzermeyer H. Gemcitabine-associated autonomic neuropathy. Lancet. 351(9103):1998;644
107. Roca E., Bruera E., Politi P.M., et al. Vinca alkaloid-induced cardiovascular autonomic neuropathy. Cancer Treat. Rep. 69(2):1985;149-151
108. Viniegra M., Marchetti M., Losso M., et al. Cardiovascular autonomic function in anthracycline-treated breast cancer patients. Cancer Chemother. Pharmacol. 26(3):1990;227-231
109. Ekholm E.M., Salminen E.K., Huikuri H.V., et al. Impairment of heart rate variability during paclitaxel therapy. Cancer. 88(9):2000;2149-2153
110. Barbey J.T., Pezzullo J.C., Soignet S.L. Effect of arsenic trioxide on QT interval in patients with advanced malignancies. J. Clin. Oncol. 21(19):2003;3609-3615
111. Fujii K., Sonoda K., Izumi K., Shiraishi N., Adachi Y., Kitano S. T lymphocyte subsets and Th1/Th2 balance after laparoscopy-assisted distal gastrectomy. Surg. Endosc. 2003;. Epub June 25
112. Tatsumi H., Ura H., Ikeda S., et al. World Surgical influence on TH1/TH2 balance and monocyte surface antigen expression and its relation to infectious complications. J. Surg. 27(5):2003;522-528